Coming Off Wegovy: What Happens to Your Body and Your Weight

You've decided to stop, here's what your body is about to do

Picture the last dose sitting in your system. Semaglutide has a half-life of roughly a week, so it clears slowly, but within four to five weeks its effects on appetite are largely gone. The receptors it was activating in the brain and gut (the ones that told you you were full sooner, made food feel less urgent) return to their pre-treatment baseline.

For most people that means hunger comes back, sometimes with force. Portion sizes that felt comfortable during treatment may suddenly feel insufficient. This isn't imagination. The NHS semaglutide medicines page notes that semaglutide works by mimicking a gut hormone that regulates appetite; when the medicine leaves, that signal goes with it.

Clinical data from the STEP extension trial (published in the New England Journal of Medicine) followed participants who stopped semaglutide after 68 weeks of treatment. On average they regained around two-thirds of the weight they had lost within the following year. Cardiometabolic markers that had improved (blood pressure, blood glucose, cholesterol) also partially reversed. These are facts worth sitting with, not because stopping is wrong, but because the plan for what comes next deserves as much thought as the decision to stop.

If Wegovy simply isn't working as expected, it's worth reading about what to do when Wegovy doesn't seem to be having an effect before concluding that stopping is the only option.

Stopping versus weaning: what actually makes sense medically

One of the most common questions our prescribers hear is whether Wegovy needs to be tapered. The short answer is that the medicine's licence does not specify a mandatory reduction schedule before stopping, it is not like some other medicines where abrupt cessation carries its own risks. You won't experience physical withdrawal in the clinical sense of the word.

That said, stepping down through lower doses over a few weeks before stopping completely is something some clinicians recommend simply because it may soften the return of appetite and give you time to reinforce the habits built during treatment. If you want to understand the practical steps involved, our page on how to wean off Wegovy sets out what a gradual approach looks like.

Equally, there is a meaningful difference between coming off Wegovy permanently and pausing it, for surgery, pregnancy planning, or a temporary supply issue. A pause followed by a restart typically means beginning again at a lower dose and re-titrating, because tolerance to the side effects fades, and if you're wondering whether Wegovy stored during a break goes off, our dedicated page covers exactly what you need to know about shelf life and storage. Your prescriber should be involved in either scenario. The process of getting off Wegovy safely looks different depending on the reason you're stopping.

For context on what Wegovy costs as part of a private treatment plan, our treatment page sets out what's included in a single transparent price, from consultation through to aftercare.

Keeping the weight off after Wegovy: what the evidence actually supports

The honest picture is that Wegovy gives most people a significant window, one in which appetite is reduced enough to build new eating habits and increase physical activity. What happens after stopping depends heavily on how that window was used, and on what support is in place afterwards.

There is no single approved protocol for post-treatment maintenance in the UK, but the NHS England guidance on weight-management injections is clear that behavioural support (diet counselling, activity planning, structured follow-up) is part of what makes treatment durable, during and after the medicine itself. That framing matters: the medicine is a tool inside a wider plan, not the plan itself.

Some people, after discussion with their prescriber, move to a different treatment rather than stopping outright. Others stop deliberately, having reached a stable weight and built habits they feel confident in. A smaller group find that after coming off of Wegovy the weight returns quickly enough that restarting becomes the most clinically sensible option, and if broader NHS access is part of your thinking, our page on when Wegovy is coming to the UK more widely explains the current rollout picture. None of these paths is more valid than the others. What matters is that the decision is made with clinical input rather than made unilaterally at the end of a supply.

If you're at the stage of thinking about semaglutide treatment more broadly (whether that means restarting Wegovy, exploring the newer oral semaglutide option, or understanding your alternatives) our prescribers can review your full history and help you think through what fits your situation. The consultation is free, and there are no obligations attached to it.